Algal Scientific closes Series B

The biotech developer and manufacturer of algae-based chemicals serving the animal health, human health and water treatment market, has closed a Series B funding round on $7 million.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.